Navigation Links
Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
Date:6/2/2008

LA JOLLA, Calif., June 2 /PRNewswire-FirstCall/ -- Alliance Pharmaceutical Corp. (OTC Bulletin Board: ALLP) announced today the results of the vote of its shareholders on the two proposals put to the shareholders at its Annual Meeting of Shareholders held Friday, May 30, 2008.

The first proposal related to the re-election of each of the six sitting directors of the Company to serve an additional term of one year or until their successors are duly elected and qualified. All six directors were re-elected by the requisite vote of the shareholders.

The second proposal related to the approval of a reverse stock split to be effected at a ratio of ten shares to one share of our common stock. As disclosed in the Company's proxy statement related to the Annual Meeting, the Company has determined that in order to obtain additional financing to further the development of Oxygent(TM), the Company's outstanding indebtedness must be converted into common stock. The holders of substantially all of this outstanding indebtedness have agreed to convert such debt into common stock at a conversion price of $0.17 per share. The material conditions to such conversion are: (i) that the company effect a reverse stock split in a ratio of ten shares of common stock to one share of common stock in order to allow for enough authorized but unissued common stock to enable such conversion; and (ii) that the Company raise at least $3 million in new financing from investors.

The shareholders of the Company approved the reverse stock split by the requisite vote. The Board of Directors of the Company is now authorized to set an effective date for the reverse stock split, and such reverse stock split will become effective on such date and at the time the Company files an amendment to its Articles of Incorporation effecting such reverse stock split. The Company expects that its Board of Directors will set the effective date of the reverse stock split in the near future.


'/>"/>
SOURCE Alliance Pharmaceutical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lung Cancer Alliance Hails Announcement of New Erbitux(R) Data
2. Lung Cancer Alliance Commends NCCN on Screening Guidelines
3. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
4. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
5. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
7. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
8. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
9. Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting
10. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
11. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 The leading ... $13 billion global cardiac rhythm management device market ... found that Medtronic, St. Jude Medical, Boston Scientific ... of this market segment. The healthcare market research ... , uses 2015 as a base year, providing ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)... OF PRUSSIA, Pa. , May 22, 2015  The ... Behring its 2015 Corporate Leadership Award as recognition for ... improving the care of the bleeding disorders community.  The award ... Director, CSL Limited, during the NHF Annual Spring Soiree in ... "The National Hemophilia Foundation is dedicated to finding ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4
... YORK, May 13, 2011 Duane Reade Holdings, Inc. today ... new fundraising record for the 26th annual AIDS Walk New ... raises funds for Gay Men,s Health Crisis (GMHC) and 41 ... care, and more to people living with HIV/AIDS, as well ...
... For the second year in a row Royce Colors - ... a supplier recognition from Carestream Health, the world,s leading manufacturer ... which supplies a complete line of Medical and Dental Imaging ... 2010 Supplier of the Year , Carestream,s top supplier ...
Cached Medicine Technology:Duane Reade Celebrates Fourth Year Supporting AIDS Walk New York With Record Donation 2Duane Reade Celebrates Fourth Year Supporting AIDS Walk New York With Record Donation 3Royce Receives Coveted Medical Products Award 2
(Date:5/22/2015)... Pasadena, Calif. (PRWEB) May 22, 2015 ... where technology, communication and capacity are intersecting to ... and across society, the opening speaker at WesternU's ... , California Lieut. Gov. Gavin Newsom, a former ... was the keynote speaker at the graduation ceremony ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... OH (PRWEB) May 22, 2015 River ... that Kyle Johnson, the health system’s Chief Financial Officer ... interests. Johnson has served as the company CFO since ... West will be joining the health system as CFO. ... an interim basis, while the Board of Trustees conducts ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health ... health brand Nature’s Way, Marc St-Onge has affirmed his ... Skin is an integral part of the agreement with ... to further develop Ascenta Skin into a leading player ... a breakthrough, anti-aging skincare supplement featuring 6 active ingredients ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2
... N.C., Sept. 21 Whether it is bragged or whispered about, ... recent study by Adam & Eve shows that for most folks, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090921/LA79100 ) , , (Logo: ... the most trusted name in adult entertainment, recently asked over 1,000 ...
... ... Traumatic Brain Injury , ... September 21, 2009 -- In the current issue of Molecular Medicine, a team of scientists ... progesterone may be beneficial in protecting the brain after traumatic injury. Traumatic brain ...
... children under 10 will need two doses, preliminary U.S. trial ... who are between 10 and 17 years old will apparently ... according to initial results of ongoing trials, U.S. health officials ... two doses of the new H1N1 vaccine, the officials added. ...
... , SACRAMENTO, Calif., Sept. 21 Former California Assembly ... a Purple Ribbon Panel and Task Force starting work today to ... double among Californians by the year 2030. The state has not ... , Brown will be joined by Lloyd Dean, Jonathan ...
... ... face transplant are offering full details about the research, preparation, actual surgery and current ... ... first near-total face transplant, the surgeons involved are offering full details about the research, ...
... , FORT WASHINGTON, Pa., Sept. 21 A ... LACTAID(R) Brand found that 77 percent of Latinas reduce the amount of ... lactose intolerance. Yet, 63 percent of Latinas who have lactose intolerance ... and vitamins A and D. Despite their concerns, only 14 percent ...
Cached Medicine News:Health News:Adam & Eve's 'Great American Sex Survey' Asks 'How Was YOUR First Time?' 2Health News:News from the Latest Issue of Molecular Medicine 2Health News:1 Swine Flu Shot Enough for Older Kids 2Health News:1 Swine Flu Shot Enough for Older Kids 3Health News:Elaine Alquist, Willie Brown and Kim Belshe Convene Purple Ribbon Panel, Task Force on Alzheimer's 2Health News:Details Emerge About Approach, Results of First US Face Transplant 2Health News:New Research Finds Latinas with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 2Health News:New Research Finds Latinas with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 3
Inquire...
... Pectoralis Implants come in three styles. Each ... by far the most popular style. Pectoral ... are packaged and sold individually, not in ... they are each made for a specific ...
... The latest software product in the IQmark ... new, more efficient levels of portability, cost-savings and ... is perfect for use in the office, clinics ... and emergency situations. , ,When used in conjunction ...
... EZ Holter is engineered to set a ... you do is enter the patient demographics, ... ,This three-channel, Windows based system uses the ... accuracy and versatility of the IQmark Holter ...
Medicine Products: